Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 667-671

  Jiang, Jiazhong ^a   Neubauer, Blake Lee ^b   Graff, Jeremy R ^b   Chedid, Marcio ^b   Thomas, James E ^b   Roehm, Neal W ^b   Zhang, Shaobo ^a   Eckert, George J ^a   Koch, Michael O ^a   Eble, John N ^a   Cheng, Liang ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; PHOSPHOLIPASE A2;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION;

EID: 0036171520     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64886-9     Document Type: Article

References (29)

1. Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells
2. Arachidonic acid metabolites in BFGF-, PDGF-, and serum-stimulated vascular cell growth
3. Signal transduction by bFGF, but not TGF beta 1, involves arachidonic acid metabolism in endothelial cells
4. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells
5. Differential activation of phospholipases during necrosis or apoptosis: A comparative study using tumor necrosis factor and anti-Fas antibodies
6. Different apoptotic pathways mediated by Fas and the tumor-necrosis-factor receptor. Cytosolic phospholipase A2 is not involved in Fas-mediated apoptosis
7. New insights on mammalian phospholipase A2(s): Comparison of arachidonyl-selective and-nonselective enzymes
8. Structure, function and regulation of mammalian phospholipases A2
9. Cytosolic phospholipase A2
10. 5,8,11,14-eicosatetraenoic acid-induced destruction of mitochondria destruction of mitochondria in human prostate cells (PC-3)
11. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines
12. Effects of dietary menhaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice
13. The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinoma
14. The effect of linoleic, arachidonic and eicosapentaenoic acid supplementation on prostacyclin production in rats
15. Increased phospholipid fatty acid remodeling in human and rat prostatic adenocarcinoma tissues
16. Neoplasms of the prostate
17. Alterations in sphingomyelin and fatty acids in human benign prostatic hyperplasia and prostatic cancer
18. Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease
19. Arachidonic acid metabolism in benign and malignant tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitors
20. Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: Plasma and tumor effusion prostaglandins
21. Secretion of group 2 phospholipase A2 by lacrimal glands
22. Synovial-type (group II) phospholipase A2 human seminal plasma
23. Synovial type (group II) phospholipase A2 in cartilage
24. Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2
25. Elevation of serum group IIa phospholipase A2 in patients with cancers of digestive organs
26. Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa
27. Increased expression of membrane-associated phospholipase A2 shows malignant potential of human breast cancer cells
28. Immunohistochemical localization of group II phospholipase A2 in human pancreatic carcinomas
29. Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer